Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 42Carcinoma, Renal Cell 12Neoplasms 11Liver Neoplasms 8Carcinoma 5Neoplasm Metastasis 4Carcinoma, Non-Small-Cell Lung 4Leukemia, Myeloid, Acute 3Kidney Neoplasms 3Melanoma 2Hepatoblastoma 2Vaccinia 1Thyroid Neoplasms 1Sarcoma, Myeloid 1Recurrence 1Radiotherapy 1Pancreatic Neoplasms 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Liver Diseases 1Fibrolamellar hepatocellular carcinoma 1Digestive System Neoplasms 1Digestive System Diseases 1Desmoid Tumors 1Breast Neoplasms 1Advanced Liver Cancer 1Adenocarcinoma 1

Interventions

Sorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Advanced Liver Cancer × Sorafenib × Clear all
NCT04163237 2019-11-14

Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer

Guangxi Medical University

Phase 3 Unknown
50 enrolled

Advanced Liver Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡